Sat, Feb 28, 2015, 3:01 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • johnpapas893 johnpapas893 Apr 2, 2013 11:28 AM Flag

    Proteasome Inhibitor Data Presentations at 14th International Myeloma Workshop

    Any views on how important these data presentations might be?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Hi, John, I have enrolled for the web broadcast on Friday (2pm PT), but I don't imagine I'll have enough patience to listen to it all. The website says that online enrollees should have received a password allowing them access to the abstracts, but I can't find any password in their e-mails. I don't expect anything earthshaking will be revealed here. A lot of the programs seem to be Big Picture discussions rather than reports of trials. If I learn anything new, I will post it here. On another note, perusing the posts on The Myeloma Beacon, I am again impressed by how dramatically effective Kyprolis is for many MM patients. Some of the early participants in the trials have now been on the drug for almost 2 years and seem to be in effective remission. It's becoming increasingly evident, I think, that Kyrpolis, rather than Velcade, should be the first line of treatment.

124.700.0000(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.